Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin

Journal of the American College of Cardiology

Volumn 44, Issue 2, 2004, Pages 451-457

  Matsumoto, Tetsuya ^a   Takashima, Hiroyuki ^a   Ohira, Naoto ^a   Tarutani, Yasuhiro ^a   Yasuda, Yo ^a   Yamane, Tetsunobu ^a   Matsuo, Shinro ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

BK; BMI; body mass index; bradykinin; CAD; CBF; coronary artery disease; coronary blood flow; HDL; high density lipoprotein; LAD; LDL; left anterior descending; low density lipoprotein; nitric oxide; NO; oxidized low density lipoprotein; oxLDL

Indexed keywords

BRADYKININ; CHOLESTEROL ESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ARTERY DIAMETER; ARTICLE; BODY MASS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; DOPPLER FLOWMETRY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIUM; FEMALE; GENDER; HUMAN; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKING; VASODILATATION; VASOMOTOR REFLEX;

ADULT; AGED; BLOOD FLOW VELOCITY; BODY MASS INDEX; BRADYKININ; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; VASODILATION;

EID: 3242697053     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.03.064     Document Type: Article

References (34)

1. Vita J.A., Treasure C.B., Nabel E.G., et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497
2. Zeiher A.M., Drexler H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 92:1993;652-662
3. Quyyumi A.A., Dakak N., Andrews N.P., et al. Nitric oxide activity in the human coronary circulation impact of risk factors for coronary atherosclerosis. J Clin Invest. 95:1995;1747-1755
4. Seiler C., Hess O.M., Buechi M., Suter T.M., Krayenbuehl H.P. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation. 88:1993;2139-2148
5. Lewis T.V., Dart A.M., Chin-Dusting J.P.F. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol. 33:1999;805-812
6. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:1989;915-924
7. Cox D.A., Cohen M.L. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation clinical and pharmacological implications in atherosclerosis. Pharmacol Rev. 48:1996;3-19
8. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:1990;160-162
9. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low-density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 86:1990;75-79
10. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012-2020
11. Anderson T.J., Meredith I.T., Charbonneau F., et al. Endothelium- dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 93:1996;1647-1650
12. Penny W.F., Ben-Yehuda O., Kuroe K., et al. Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein. J Am Coll Cardiol. 37:2001;766-774
13. Suwaidi J.A., Hamasaki S., Higano S.T., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 101:2000;948-954
14. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 101:2000;1899-1906
15. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 98:1998;1487-1494
16. Tsimikas S., Bergmark C., Beyer R.W., et al. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol. 41:2003;360-370
17. Groves P., Kurz S., Just H., Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation. 92:1995;3424-3430
18. Nakashima M., Mombouli J.-V., Taylor A.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 92:1993;2867-2871
19. Minai K., Matsumoto T., Horie H., et al. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation effects of angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 37:2001;1565-1570
20. Matsumoto T., Minai K., Horie H., et al. Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients. J Am Coll Cardiol. 41:2003;1373-1379
21. Kohno H., Sueshige N., Oguri K., et al. Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody. Clin Biochem. 33:2000;243-253
22. Itabe H., Yamamoto H., Imanaka T., et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res. 37:1996;45-53
23. Keaney J.F. Jr., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 23:2003;434-439
24. Ehara S., Ueda M., Naruko T., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndrome. Circulation. 103:2001;1955-1960
25. Tsutamoto T., Wada A., Matsumoto T., et al. Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing heart of patients with dilated cardiomyopathy. J Am Coll Cardiol. 37:2001;2086-2092
26. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 95:1997;588-593
27. Makimattila S., Liu M.-L., Vakkilainen J., et al. Impaired endothelium-dependent vasodilation in type 2 diabetes relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care. 22:1999;973-981
28. Al Suwaidi J., Higano S.T., Holmes D.R., Lennon R., Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 37:2001;1523-1528
29. Chan N.N., Colhoun H.M., Vallance P. Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol. 38:2001;1814-1820
30. Perticone F., Ceravolo R., Candigliota M., et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress protective effect of vitamin C. Diabetes. 50:2001;159-165
31. Zeiher A.M., Schachinger V., Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 92:1995;1094-1100
32. Heitzer T., Yla-Herttuala S., Luoma J., et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia role of oxidized LDL. Circulation. 93:1996;1346-1353
33. Dart A.M., Chin-Dusting J.P. Review lipids and the endothelium. Cardiovasc Res. 43:1999;308-322
34. Heitzer T., Schlinzig T., Krohn K., et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 104:2001;2673-2678